ST
Seres Therapeutics Inc
🇺🇸XNAS.MCRBUnited StatesHealthcare
$4.60USDdown -0.13 (-2.75%)OpenEnd of day6:03 PM
Price$4.60-0.13 (-2.75%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US81750R2013
- CUSIP
- 81750R102
Company
- Employees
- 66
- Headquarters
- Cambridge, United States
- CEO
- Mr. Richard N. Kender B.S., M.B.A.
Market
- Shares outstanding
- 10M
- Market cap
- $46.21M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $46.21M
- EPS LTM
- -$2.24calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -2.06calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.88M-68.4%down year on year
- Net income
- -$22.46M-126.13%down year on year
- Gross margin
- 82.58%+195.35%up year on year
- Free cash flow
- -$51.3M+15.04%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.